In the high-stakes world of acute care, communication barriers with patients who have limited English proficiency can lead to mistakes that are hard to believe if they didn’t happen to you. Join our upcoming Safe Table forum “ They Put A What in my What?! : Preventing Harm to Patients with Limited English Proficiency (LEP),” and share your story of tackling these challenges head-on. Through real-world examples and practical solutions, we’ll discuss how to navigate language barriers and reduce harm, even when things get lost in translation.
Prescriptions for semaglutide, marketed under the names Ozempic and Wegovy, surged almost 3,000% in the U.S. from 2018 to 2022.
Encounters of gallbladder inflammation in California hospitals surged by 492% during the study period, potentially linked to the slowed digestion caused by long-term semaglutide use.
Hospital encounters in California related to acute kidney injuries rose by 18% and cases of low blood sugar (hypoglycemia) increased by 27%, suggesting these may be emerging areas of concern for semaglutide users.
We here at HQI are excited about the year ahead and continuing the collaborative work of enhancing patient safety and fostering a culture of excellence within hospitals. Our role is to support our members’ efforts toward providing the safest and highest quality care possible through education and the sharing of information and resources.
About HQI’s Sentinel Signal Detection System Report HQI’s sentinel signal detection system automatically detects abnormal changes (i.e., signals) in the incidence of diagnosis categories from hospital encounter records in the Hospital Quality Improvement Platform (HQIP). Every quarter, HQI aggregates these signals across reporting hospitals to provide a statewide perspective. Emergency Department With Q3 2024 encompassing the […]